Atlas Trials

wAMD

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch wAMD

RecordFirmDate
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 (NCT06683742)EyePoint Pharmaceuticals, Inc.2024-11-27
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 (NCT06668064)EyePoint Pharmaceuticals, Inc.2024-10-22
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (NCT05407636)AbbVie2022-01-13
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD (NCT04704921)AbbVie2020-12-29

Track wAMD automatically

Every clearance here is in the API, with alerts when new ones post.